Jeffrey T. Walsh, Chief Strategy Officer at bluebird bio, Inc. (BLUE), sold 1,500 shares at $132.38 ($198K) on 2019-05-10, disclosed to the SEC on 2019-05-14.
Open-market sale of $198k BLUE by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.11 | 200 | $26K | 13.2% |
| 2 | $132.38 | 1,100 | $146K | 73.4% |
| 3 | $133.08 | 200 | $27K | 13.4% |
| Total | $132.30 avg | 1,500 | $198K | 100% |
| Filing → |
| BLUE | SELL | 2019-06-12 | $176K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |
| BLUE | SELL | 2019-03-13 | $419K | — | Filing → |